Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Jan;36(1):227–229. doi: 10.1128/aac.36.1.227

Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential.

K Suomalainen 1, T Sorsa 1, L M Golub 1, N Ramamurthy 1, H M Lee 1, V J Uitto 1, H Saari 1, Y T Konttinen 1
PMCID: PMC189275  PMID: 1317148

Abstract

The concentrations of doxycycline and 4-de-dimethylaminotetracycline required to inhibit 50% of collagenase activity were found to be 15 to 30 microM for human neutrophil and gingival crevicular fluid collagenases. Fibroblast collagenase was relatively resistant to inhibition by tetracyclines; the 50% inhibitory concentrations of doxycycline and 4-de-dimethylaminotetracycline were 280 and 510 microM, respectively.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birkedal-Hansen H. From tadpole collagenase to a family of matrix metalloproteinases. J Oral Pathol. 1988 Nov;17(9-10):445–451. doi: 10.1111/j.1600-0714.1988.tb01313.x. [DOI] [PubMed] [Google Scholar]
  2. Breedveld F. C., Dijkmans B. A., Mattie H. Minocycline treatment for rheumatoid arthritis: an open dose finding study. J Rheumatol. 1990 Jan;17(1):43–46. [PubMed] [Google Scholar]
  3. Bunning R. A., Murphy G., Kumar S., Phillips P., Reynolds J. J. Metalloproteinase inhibitors from bovine cartilage and body fluids. Eur J Biochem. 1984 Feb 15;139(1):75–80. doi: 10.1111/j.1432-1033.1984.tb07978.x. [DOI] [PubMed] [Google Scholar]
  4. Burns F. R., Stack M. S., Gray R. D., Paterson C. A. Inhibition of purified collagenase from alkali-burned rabbit corneas. Invest Ophthalmol Vis Sci. 1989 Jul;30(7):1569–1575. [PubMed] [Google Scholar]
  5. Desrochers P. E., Weiss S. J. Proteolytic inactivation of alpha-1-proteinase inhibitor by a neutrophil metalloproteinase. J Clin Invest. 1988 May;81(5):1646–1650. doi: 10.1172/JCI113500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gangbar S., Overall C. M., McCulloch C. A., Sodek J. Identification of polymorphonuclear leukocyte collagenase and gelatinase activities in mouthrinse samples: correlation with periodontal disease activity in adult and juvenile periodontitis. J Periodontal Res. 1990 Sep;25(5):257–267. doi: 10.1111/j.1600-0765.1990.tb00914.x. [DOI] [PubMed] [Google Scholar]
  7. Goldberg G. I., Wilhelm S. M., Kronberger A., Bauer E. A., Grant G. A., Eisen A. Z. Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem. 1986 May 15;261(14):6600–6605. [PubMed] [Google Scholar]
  8. Golub L. M., Ciancio S., Ramamamurthy N. S., Leung M., McNamara T. F. Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodontal Res. 1990 Nov;25(6):321–330. doi: 10.1111/j.1600-0765.1990.tb00923.x. [DOI] [PubMed] [Google Scholar]
  9. Golub L. M., Lee H. M., Lehrer G., Nemiroff A., McNamara T. F., Kaplan R., Ramamurthy N. S. Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. J Periodontal Res. 1983 Sep;18(5):516–526. doi: 10.1111/j.1600-0765.1983.tb00388.x. [DOI] [PubMed] [Google Scholar]
  10. Golub L. M., McNamara T. F., D'Angelo G., Greenwald R. A., Ramamurthy N. S. A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J Dent Res. 1987 Aug;66(8):1310–1314. doi: 10.1177/00220345870660080401. [DOI] [PubMed] [Google Scholar]
  11. Gordon J. M., Walker C. B., Murphy J. C., Goodson J. M., Socransky S. S. Tetracycline: levels achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part I. Concentrations in crevicular fluid after repeated doses. J Periodontol. 1981 Oct;52(10):609–612. doi: 10.1902/jop.1981.52.10.609. [DOI] [PubMed] [Google Scholar]
  12. Hasty K. A., Pourmotabbed T. F., Goldberg G. I., Thompson J. P., Spinella D. G., Stevens R. M., Mainardi C. L. Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J Biol Chem. 1990 Jul 15;265(20):11421–11424. [PubMed] [Google Scholar]
  13. Humbert P., Renaud A., Laurent R., Agache P. Tetracyclines for dystrophic epidermolysis bullosa. Lancet. 1989 Jul 29;2(8657):277–277. doi: 10.1016/s0140-6736(89)90461-3. [DOI] [PubMed] [Google Scholar]
  14. Lin H. Y., Wells B. R., Taylor R. E., Birkedal-Hansen H. Degradation of type I collagen by rat mucosal keratinocytes. Evidence for secretion of a specific epithelial collagenase. J Biol Chem. 1987 May 15;262(14):6823–6831. [PubMed] [Google Scholar]
  15. McCulloch C. A., Birek P., Overall C., Aitken S., Lee W., Kulkarni G. Randomized controlled trial of doxycycline in prevention of recurrent periodontitis in high-risk patients: antimicrobial activity and collagenase inhibition. J Clin Periodontol. 1990 Oct;17(9):616–622. [PubMed] [Google Scholar]
  16. Michaelis J., Vissers M. C., Winterbourn C. C. Human neutrophil collagenase cleaves alpha 1-antitrypsin. Biochem J. 1990 Sep 15;270(3):809–814. doi: 10.1042/bj2700809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Okada Y., Nagase H., Harris E. D., Jr A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J Biol Chem. 1986 Oct 25;261(30):14245–14255. [PubMed] [Google Scholar]
  18. Saari H., Suomalainen K., Lindy O., Konttinen Y. T., Sorsa T. Activation of latent human neutrophil collagenase by reactive oxygen species and serine proteases. Biochem Biophys Res Commun. 1990 Sep 28;171(3):979–987. doi: 10.1016/0006-291x(90)90780-q. [DOI] [PubMed] [Google Scholar]
  19. Sorsa T., Uitto V. J., Suomalainen K., Vauhkonen M., Lindy S. Comparison of interstitial collagenases from human gingiva, sulcular fluid and polymorphonuclear leukocytes. J Periodontal Res. 1988 Nov;23(6):386–393. doi: 10.1111/j.1600-0765.1988.tb01618.x. [DOI] [PubMed] [Google Scholar]
  20. Taylor M. A. Methodology in psychotherapy research. Am J Psychiatry. 1978 Jan;135(1):129–130. doi: 10.1176/ajp.135.1.aj1351129. [DOI] [PubMed] [Google Scholar]
  21. Uitto V. J., Suomalainen K., Sorsa T. Salivary collagenase. Origin, characteristics and relationship to periodontal health. J Periodontal Res. 1990 May;25(3):135–142. doi: 10.1111/j.1600-0765.1990.tb01035.x. [DOI] [PubMed] [Google Scholar]
  22. Walker C. B., Gordon J. M., McQuilkin S. J., Niebloom T. A., Socransky S. S. Tetracycline: levels of achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part II. Susceptibilities of periodontal bacteria. J Periodontol. 1981 Oct;52(10):613–616. doi: 10.1902/jop.1981.52.10.613. [DOI] [PubMed] [Google Scholar]
  23. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]
  24. Welgus H. G., Campbell E. J., Bar-Shavit Z., Senior R. M., Teitelbaum S. L. Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J Clin Invest. 1985 Jul;76(1):219–224. doi: 10.1172/JCI111949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. White J. E. Minocycline for dystrophic epidermolysis bullosa. Lancet. 1989 Apr 29;1(8644):966–966. doi: 10.1016/s0140-6736(89)92555-5. [DOI] [PubMed] [Google Scholar]
  26. Zucker S., Wieman J., Lysik R. M., Imhof B., Nagase H., Ramamurthy N., Liotta L. A., Golub L. M. Gelatin-degrading type IV collagenase isolated from human small cell lung cancer. Invasion Metastasis. 1989;9(3):167–181. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES